CHINA PHARMA HOLDINGS INC (CPHI)
US16941T3023 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 1.42M | 2.00M | 4.90M | 1.00M | 1.10M | |||
| Receivables | 730.32K | 900.00K | 800.00K | 600.00K | 700.00K | |||
| Inventories | 3.73M | 2.90M | 3.30M | 3.70M | 3.60M | |||
| Other Current Assets | 110.26K | 100.00K | 100.00K | 100.00K | 200.00K | |||
| Total Current Assets | 6.00M | 6.00M | 9.10M | 5.30M | 5.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 7.22M | 10.00M | 13.40M | 15.60M | 16.50M | |||
| Intangibles | 3.26M | 1.80M | 100.00K | 200.00K | 200.00K | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | 0.00 | |||
| Total Non-Current Assets | 10.47M | 11.80M | 13.50M | 15.80M | 16.60M | |||
| TOTAL ASSETS | 16.47M | 17.80M | 22.60M | 21.10M | 22.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 1.97M | 6.20M | 4.30M | 2.00M | 100.00K | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 2.30M | 2.20M | |||
| Accrued Expenses | 376.56K | 400.00K | 400.00K | 200.00K | 300.00K | |||
| Accounts Payable | 966.42K | 700.00K | 900.00K | 1.20M | 1.40M | |||
| Other Current Liabilities | 3.51M | 5.40M | 4.90M | 5.60M | 6.10M | |||
| Total Current Liabilities | 6.82M | 12.70M | 10.50M | 11.40M | 10.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 1.41M | 0.00 | 5.30M | 900.00K | 2.20M | |||
| Deferred Taxes/Income | 742.11K | 800.00K | 800.00K | 800.00K | 800.00K | |||
| Other Non-Current Liabilities | 39.91K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Total Non-Current Liabilities | 2.19M | 800.00K | 6.10M | 1.70M | 3.00M | |||
| TOTAL LIABILITIES | 9.01M | 13.50M | 16.60M | 13.10M | 13.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -39.29M | -36.20M | -32.20M | -28.80M | -26.00M | |||
| Additional Paid In Capital | 35.28M | 28.90M | 25.60M | 24.50M | 23.60M | |||
| Common Shares | 10.63K | 100.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 11.45M | 11.60M | 12.60M | 12.30M | 11.60M | |||
| Shares Outstanding | 10.63M | 7.50M | 4.70M | 4.60M | 4.40M | |||
| Tangible Book Value per Share | 0.40 | 0.33 | 1.26 | 1.70 | 2.05 | |||
| Total Shareholders' Equity | 7.45M | 4.30M | 6.00M | 8.00M | 9.20M | |||
| TOTAL LIABILITIES AND EQUITY | 16.47M | 17.80M | 22.60M | 21.10M | 22.20M | |||
| Statistics | ||||||||
| Debt/Equity | 0.45 | N/A | 1.60 | 0.36 | 0.25 | |||
| Current Ratio | 0.88 | 0.47 | 0.87 | 0.46 | 0.56 | |||
| Return On Assets (ROA) | -18.69% | -22.30% | -15.04% | -13.60% | -93.24% | |||
| Return On Equity (ROE) | -41.30% | -92.33% | -56.67% | -35.88% | -225.00% | |||
All data in USD